Skip to content

Effects and Mechanisms of Repetitive Transcranial Magnetic Stimulation (rTMS) on Patients with Chronic Pain of Knee Osteoarthritis Complicated with Mild Cognitive Impairment

Effects and Mechanisms of Repetitive Transcranial Magnetic Stimulation (rTMS) on Patients with Chronic Pain of Knee Osteoarthritis Complicated with Mild Cognitive Impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126819
Enrollment
Unknown
Registered
2026-06-16
Start date
2026-06-18
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis (KOA)

Interventions

Group1:Real stimulation of the OFC and SMA
Group 2:Verum OFC + Sham SMA group
Group 3:Sham OFC +Verum SMA group
Group 4:Sham OFC stimulation + Sham SMA stimulation

Sponsors

Xiangyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for knee osteoarthritis (referencing the 1986 American Rheumatism Association's criteria for knee osteoarthritis): (1) X-rays show marginal bone formation in the joint; (2) Knee problems (within one month before the visit, pain lasting >=14 days); (3) Synovial fluid: clear, viscous, WBC 40 years; (5) Morning stiffness of the knee = 3 months. 5. K/L grade (radiological diagnosis standard by Kellgren and Lawrence) >= 2; 6. WOMAC pain subscale score >= 40; 7. BPI pain score > 2 within one week of enrollment; 8. BDI score < 14, Hamilton Anxiety Scale score < 14; 9. Complaints of memory decline; 10. Montreal Cognitive Assessment (MoCA) score: illiterate < 14, elementary school < 20, middle school and above < 25; 11. Right-handed; 12. Informed consent and voluntary participation.

Exclusion criteria

Exclusion criteria: 1. People with a tendency to bleed; 2. History of knee surgery in the past six months (like arthroscopy) or intra-articular corticosteroid injection in the past three months; 3. Knee pain caused by rheumatic diseases; 4. Having primary or secondary muscle diseases (like idiopathic inflammatory myopathy, progressive muscular dystrophy, glycogen storage disease, etc.); 5. Mental disorders, poor vision, inability to act independently, or unwillingness to cooperate with clinical observation and treatment; 6. Severe organ failure or serious cardiovascular and cerebrovascular system diseases; 7. Women who are pregnant or breastfeeding; 8. Having contraindications for MRI such as non-removable dentures, pacemakers, or taking drugs affecting brain imaging like opioids or benzodiazepines; anyone who meets any of these is not included.

Design outcomes

Primary

MeasureTime frame
Pain Score;

Secondary

MeasureTime frame
Safety outcomes;Knee joint function;Pain Catastrophizing Scale (PCS);Quality of life (QoL);neuroimaging parameters;Emotional state;Motor function;Blood biomarkers;Cognitive function;

Countries

China

Contacts

Public ContactQianqian Sun

Xiangyang Central Hospital

1418065120@qq.com+86 17850862030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026